<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Weighted Deduction Allowed for Clinical Trial Expenses u/s 35(2AB) of Income Tax Act to Boost R&amp;D Incentives.</title>
    <link>https://www.taxtmi.com/highlights?id=70683</link>
    <description>Weighted deduction for expenses incurred towards clinical trial expenses - Explanation to section 35(2AB) - The section allows the expenditure incurred towards clinical trial by the approved entity and, therefore, we see no reason to deny the benefit of weighted deduction or the expenditure incurred by the assessee towards clinical trial - AT</description>
    <language>en-us</language>
    <pubDate>Sat, 01 Jul 2023 10:07:22 +0530</pubDate>
    <lastBuildDate>Sat, 01 Jul 2023 11:16:11 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=718275" rel="self" type="application/rss+xml"/>
    <item>
      <title>Weighted Deduction Allowed for Clinical Trial Expenses u/s 35(2AB) of Income Tax Act to Boost R&amp;D Incentives.</title>
      <link>https://www.taxtmi.com/highlights?id=70683</link>
      <description>Weighted deduction for expenses incurred towards clinical trial expenses - Explanation to section 35(2AB) - The section allows the expenditure incurred towards clinical trial by the approved entity and, therefore, we see no reason to deny the benefit of weighted deduction or the expenditure incurred by the assessee towards clinical trial - AT</description>
      <category>Highlights</category>
      <law>Income Tax</law>
      <pubDate>Sat, 01 Jul 2023 10:07:22 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=70683</guid>
    </item>
  </channel>
</rss>